Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$2.90 USD
+0.06 (2.11%)
Updated Jul 22, 2024 03:59 PM ET
After-Market: $2.87 -0.03 (-1.03%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.28 | 0.00% |
Earnings Summary
For their last quarter, Acasti Pharma (ACST) reported earnings of -$0.18 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 48.57%. Look out for ACST's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.28 per share, reflecting a year-over-year increase of 17.65%.
Earnings History
Price & Consensus
Zacks News for ACST
TEVA Q3 Earnings In Line, Sales Beat, Revenue View Raised
ACST: What are Zacks experts saying now?
Zacks Private Portfolio Services